US2020347239A1
|
|
Plasma spray material
|
JP2020070252A
|
|
Neoadjuvant
|
WO2018221735A1
|
|
Novel oligonucleotides
|
WO2019150514A1
|
|
Method for producing purified magnesium salt
|
CN109890370A
|
|
Haemodialysis A agent
|
JP2018168032A
|
|
Anhydrous calcium hydrogen phosphate, and method for producing the same
|
EP3533777A1
|
|
Higher-order acetate compound, and solid dialysis agent using same
|
JP2018011560A
|
|
Iron-containing food or beverage
|
EP3284717A1
|
|
Powder containing ferric pyrophosphate and method for producing same
|
JP2017064620A
|
|
Composition for melanin adsorption
|
JP2016222606A
|
|
Oily substance-containing powder composition
|
JP2016209485A
|
|
Granulated substance for dialysis a agent and preparation method thereof
|
JP2015214691A
|
|
Oils and fats refining agent
|
JP2016199442A
|
|
Powder containing ferric pyrophosphate and method for producing same
|
EP3127865A1
|
|
Powdered tobermorite type calcium silicate-based material and method for producing same
|
JP2016135684A
|
|
Sodium chloride packed in container and preservation method of sodium chloride
|
JP2016135829A
|
|
Hygroscopic inorganic filler-containing polyolefin composition and molded article using the same
|
JP2016112062A
|
|
Producing method of granules used in dialysis agent a
|
WO2015068793A1
|
|
Powdered gyro-light-type calcium silicate having high oil absorbency and large particle diameter, and production method therefor
|
JP2016069365A
|
|
Lanthanum low absorption type oral phosphorus adsorbent
|